期刊名称：JOURNAL OF EXTRACELLULAR VESICLES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
Journal of Extracellular Vesicles is the official journal of the International Society for Extracellular Vesicles. It provides a much-needed forum for the exchange of data, ideas and information from all areas pertaining to the chemistry, biology and/or applications of extracellular vesicles, including microvesicles, exosomes, ectosomes, apoptotic bodies and other extracellular vesicles. Specific areas of interest include, but are not limited to:
- Cellular and molecular mechanisms relating to the production of extracellular vesicles
- Cellular mechanisms including membrane traffic, protein sorting related to vesicle releases
- Utilization of extracellular vesicles as biomarkers
- Technological advances in isolation, quantification and characterization of the vesicles
- Extracellular vesicles and diseases
- Role of extracellular vesicles in biology
- Signal transduction, uptake and propagation of extracellular vesicles
- Structural biology of extracellular vesicles
- Stem cell biology and extracellular vesicles
- Informational databases as resources, including large sets of data on genomics, lipidomics, proteomics, high-throughput screening data, and beyond
- Utilization of extracellular vesicles for pharmacological, immunological or genetic therapies
Types of articles
Journal of Extracellular Vesicles welcomes Original research papers, Review articles, Short communications, Technical notes, Hypotheses, Position papers, Editorials, and Letters to the Editor. Supplementary material in the form of large datasets, protocols, videos etc. is encouraged.
All papers are published online immediately after they have been accepted and proofs finalized. Thematic clusters of articles (special issues) and Supplements are published occasionally and are collated into online collections published at one and the same time. Abstracts from The Society’s annual meetings are also published in the journal.
Instructions to Authors
This journal uses Editorial Manager to peer review manuscript submissions. Please read the guide for Editorial Manager authors before making a submission. Complete guidelines for preparing and submitting your manuscript to this journal are provided below. 
This title utilises format-free submission. Authors may submit their paper in any scholarly format or layout. References can be in any style or format, so long as a consistent scholarly citation format is applied. For more detail see the format-free submission section below.
Contents
About the Journal
Journal of Extracellular Vesicles is an Open Access international, peer-reviewed journal publishing high-quality, original research. Please see the journal's Aims & Scope for information about its focus and peer-review policy.
Open Access means you can publish your research so it is free to access online as soon as it is published, meaning anyone can read (and cite) your work. Please see our guide to Open Access for more information. Many funders mandate publishing your research open access; you can check open access funder policies and mandates here.
Please note that this journal only publishes manuscripts in English.
Journal of Extracellular Vesicles accepts the following types of articles: Original research articles, Review articles, Case reports, Meeting reports and Technical reports.
Article Publishing Charge
The standard article publishing charge (APC) for this journal is €1800/$2034/£1566, for up to 7 pages. The APC for Short Communication up to 4 typeset pages is: €950/$1074/£827. Articles exceeding these page limits will incur an additional charge of: €70/$79/£61 per page. Depending on your location, these charges may be subject to local taxes.Members receive a special rate on the cost of publication. For a 7 pages article (950€) and a 4 pages short text (500€). Please declare your membership on submission of your manuscript in order to receive the discounted APC rate.. Depending on your location, these charges may be subject to local taxes.
Find out more about article publishing charges and funding options.
Peer Review
Taylor & Francis is committed to peer-review integrity and upholding the highest standards of review. Once your paper has been assessed for suitability by the editor, it will then be double blind peer reviewed by independent, anonymous expert referees. Find out more about what to expect during peer review and read our guidance on publishing ethics.
Preparing Your Paper
All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).
Structure
Your paper should be compiled in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list).
Word Limits
Please include a word count for your paper. There are no word limits for papers in this journal.
Format-Free Submission
Authors may submit their paper in any scholarly format or layout. Manuscripts may be supplied as single or multiple files. These can be Word, rich text format (rtf), open document format (odt), or PDF files. Figures and tables can be placed within the text or submitted as separate documents. Figures should be of sufficient resolution to enable refereeing.
- There are no strict formatting requirements, but all manuscripts must contain the essential elements needed to evaluate a manuscript: abstract, author affiliation, figures, tables, funder information, and references. Further details may be requested upon acceptance.
- References can be in any style or format, so long as a consistent scholarly citation format is applied. Author name(s), journal or book title, article or chapter title, year of publication, volume and issue (where appropriate) and page numbers are essential. All bibliographic entries must contain a corresponding in-text citation. The addition of DOI (Digital Object Identifier) numbers is recommended but not essential.
- The journal reference style will be applied to the paper post-acceptance by Taylor & Francis.
- Spelling can be US or UK English so long as usage is consistent.
Note that, regardless of the file format of the original submission, an editable version of the article must be supplied at the revision stage.
Taylor & Francis Editing Services
To help you improve your manuscript and prepare it for submission, Taylor & Francis provides a range of editing services. Choose from options such as English Language Editing, which will ensure that your article is free of spelling and grammar errors, Translation, and Artwork Preparation. For more information, including pricing, visit this website.
Checklist: What to Include
- Author details. Please ensure everyone meeting the International Committee of Medical Journal Editors (ICMJE) requirements for authorship is included as an author of your paper. All authors of a manuscript should include their full name and affiliation on the cover page of the manuscript. Where available, please also include ORCiDs and social media handles (Facebook, Twitter or LinkedIn). One author will need to be identified as the corresponding author, with their email address normally displayed in the article PDF (depending on the journal) and the online article. Authors’ affiliations are the affiliations where the research was conducted. If any of the named co-authors moves affiliation during the peer-review process, the new affiliation can be given as a footnote. Please note that no changes to affiliation can be made after your paper is accepted. Read more on authorship.
- A non-structured abstract of more than 150 words and no more than 300 words. Read tips on writing your abstract.
- Keywords. Read making your article more discoverable, including information on choosing a title and search engine optimization.
- Funding details. Please supply all details required by your funding and grant-awarding bodies as follows:
For single agency grants
This work was supported by the [Funding Agency] under Grant [number xxxx].
For multiple agency grants
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].
- Disclosure statement. This is to acknowledge any financial interest or benefit that has arisen from the direct applications of your research.Please include a disclosure of interest statement, using the subheading "Disclosure of interest." If you have no interests to declare, please state this (suggested wording: The authors report no conflicts of interest). For all NIH/Wellcome-funded papers, the grant number(s) must be included in the disclosure of interest statement. Further guidance on what is a conflict of interest and how to disclose it.
- Geolocation information. Submitting a geolocation information section, as a separate paragraph before your acknowledgements, means we can index your paper’s study area accurately in JournalMap’s geographic literature database and make your article more discoverable to others. Make your article more discoverable to others.
- Supplemental online material. Supplemental material can be a video, dataset, fileset, sound file or anything which supports (and is pertinent to) your paper. However, unless clearly justified by the authors, all figures displaying experimental results must go into the main body of the article, none should be put in supplementary data.We publish supplemental material online via Figshare. Find out more about supplemental material and how to submit it with your article.
- Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size). Figures should be saved as TIFF, PostScript or EPS files. More information on how to prepare artwork. Readers should be able to interpret the figures with their legends without reference to the text.
- Tables. Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text. Please supply editable files.
- Equations. If you are submitting your manuscript as a Word document, please ensure that equations are editable. More information about mathematical symbols and equations.
- Units. Please use SI units (non-italicized).
- Articles must strictly follow the following recommendations for nomenclature and presentation of experimental protocols and results:
1. For nomenclature, follow recommendations of Gould and Raposo, J Extracell Vesicles 2013, 2: 20389, DOI: 10.3402/jev.v2i0.20389).
Specifically: use the generic term EVs at least in abstract and keywords.
Choice of a more precise term (microvesicles, oncosomes, microparticles, ectosomes, exosomes, or other) must be accompanied by a
clear definition of the author's meaning behind this term.
In particular, when using the term "exosomes", explain if it designs any small EV recovered by high-speed centrifugation and/or filtration,
or specifically late endosome-derived small EVs. If the latter, demonstration of the late endosome origin of the vesicles must be included.
2. For experimental set ups of EV studies, follow the "MISEV guidelines" published by ISEV (on characterization, demonstration of
EV-associated functions): see Lötvall et al, 2014, J Extracell Vesicles 3: 26913, DOI: 10.3402/jev.v3.2691.
In addition, authors are encouraged to submit their experimental protocols to the EVTRACK database ( http://evtrack.org), and provide
for editors and reviewers the tracking number and tracking score: see Van Deun, J., et al. (2017),
Nat Methods 14(3): 228-232, DOI: 10.1038/nmeth.4185.
3. For representation, bar graphs must be avoided as much as possible, figures should be presented as dot plots showing individual results
of individual biological replicates, or box-plots (with median and quartiles) if more easy to read: see Weissgerber et al 2015, Plos Biol 13:
e1002128, DOI: doi: 10.1371/journal.pbio.1002128.
-
Materials and Methods must provide all details of the experimental protocols required for reproduction of the results.
For EV isolation: conditions for harvesting fluids for EV isolation (additives when collecting biofluids, pre-processing of tissue culture
medium= eg for elimination of serum EVs, time of conditioning, etc); type of rotor and time of centrifugation/or g force used, volume of chromatography fractions, etc.
For EV characterization: volume or amount of EV materials used for biochemical characterization and functional studies, yield of vesicles (amount of protein, or of particles / volume of fluid), precise settings for acquisition and for analysis of individual particle tracking/analysing devices (eg Nanoparticle Tracking Analyzers, Dynamic Light Scattering, resistive pulse sensors, high resolution flow cytometers, or others), exact references of antibodies (provider, clone name, use in reducing/non-reducing conditions), position of molecular weight markers on cropped images and uncropped images of Western blots as supplementary figures, examples of dot plots and gatings for single particle analysers (flow cytometers, nanoparticle-tracking analyzers, etc).
Information on whether and how the authors proceed with verification of cell lines, mycoplasma contamination, and endotoxin contamination must be provided.
Using Third-Party Material in your Paper
You must obtain the necessary permission to reuse third-party material in your article. The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission. If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission. More information on requesting permission to reproduce work(s) under copyright.
Disclosure Statement
Please include a disclosure statement, using the subheading “Disclosure of interest.” If you have no interests to declare, please state this (suggested wording: The authors report no conflict of interest). For all NIH/Wellcome-funded papers, the grant number(s) must be included in the declaration of interest statement. Read more on declaring conflicts of interest.
Clinical Trials Registry
In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository at the beginning of the research process (prior to patient enrolment). Trial registration numbers should be included in the abstract, with full details in the methods section. The registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization. For a list of registries that meet these requirements, please visit the WHO International Clinical Trials Registry Platform (ICTRP). The registration of all clinical trials facilitates the sharing of information among clinicians, researchers, and patients, enhances public confidence in research, and is in accordance with the ICMJE guidelines.
Complying With Ethics of Experimentation
Please ensure that all research reported in submitted papers has been conducted in an ethical and responsible manner, and is in full compliance with all relevant codes of experimentation and legislation. All papers which report in vivo experiments or clinical trials on humans or animals must include a written statement in the Methods section. This should explain that all work was conducted with the formal approval of the local human subject or animal care committees (institutional and national), and that clinical trials have been registered as legislation requires. Authors who do not have formal ethics review committees should include a statement that their study follows the principles of the Declaration of Helsinki.
Consent
All authors are required to follow the ICMJE requirements on privacy and informed consent from patients and study participants. Please confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any research, experiment, or clinical trial described in your paper has given written consent to the inclusion of material pertaining to themselves, that they acknowledge that they cannot be identified via the paper; and that you have fully anonymized them. Where someone is deceased, please ensure you have written consent from the family or estate. Authors may use this Patient Consent Form, which should be completed, saved, and sent to the journal if requested.
Health and Safety
Please confirm that all mandatory laboratory health and safety procedures have been complied with in the course of conducting any experimental work reported in your paper. Please ensure your paper contains all appropriate warnings on any hazards that may be involved in carrying out the experiments or procedures you have described, or that may be involved in instructions, materials, or formulae.
Please include all relevant safety precautions; and cite any accepted standard or code of practice. Authors working in animal science may find it useful to consult the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare and Guidelines for the Treatment of Animals in Behavioural Research and Teaching. When a product has not yet been approved by an appropriate regulatory body for the use described in your paper, please specify this, or that the product is still investigational.
Submitting Your Paper
This journal uses Editorial Manager to manage the peer-review process. If you haven't submitted a paper to this journal before, you will need to create an account in Editorial Manager. Please read the guidelines above and then submit your paper in the relevant Author Centre, where you will find user guides and a helpdesk.
Please note that Journal of Extracellular Vesicles uses Crossref™ to screen papers for unoriginal material. By submitting your paper to Journal of Extracellular Vesicles you are agreeing to originality checks during the peer-review and production processes.
On acceptance, we recommend that you keep a copy of your Accepted Manuscript. Find out more about sharing your work.
Copyright Options
Copyright allows you to protect your original material, and stop others from using your work without your permission. Taylor & Francis offers a number of different license and reuse options, including Creative Commons licenses when publishing open access. Read more on publishing agreements.
Complying with Funding Agencies
We will deposit all National Institutes of Health or Wellcome Trust-funded papers into PubMedCentral on behalf of authors, meeting the requirements of their respective open access policies. If this applies to you, please tell our production team when you receive your article proofs, so we can do this for you. Check funders’ open access policy mandates here. Find out more about sharing your work.
My Authored Works
On publication, you will be able to view, download and check your article’s metrics (downloads, citations and Altmetric data) via My Authored Works on Taylor & Francis Online. This is where you can access every article you have published with us, as well as your free eprints link, so you can quickly and easily share your work with friends and colleagues.
We are committed to promoting and increasing the visibility of your article. Here are some tips and ideas on how you can work with us to promote your research.
Article Reprints
You will be sent a link to order article reprints via your account in our production system. For enquiries about reprints, please contact the Taylor & Francis Author Services team at reprints@tandf.co.uk.
Queries
Should you have any queries, please visit our Author Services website or contact us here.
Updated 31-08-2018
Editorial Board
Editors-in-Chief
Peter J. Quesenberry, Brown University, United States
Yong Song Gho, Pohang University of Science and Technology, Korea
Clotilde Thery, Institut Curie, INSERM, France
Associate Editors
Elena Aikawa, Harvard Medical School, United States
Chantal Boulanger, INSERM, Paris Cardiovascular Research Centre, France
Edit I. Buzás, Semmelweis University, Hungary
Giovanni Camussi, University Torino, Italy
Emanuele Cocucci, Comprehensive Cancer Center, Ohio State University, United States
Dolores Di Vizio, Cedars-Sinai Medical Center, United States
Paul Harrison, University of Birmingham, United Kingdom
Andrew Hill, Department of Biochemsitry and Genetics La Trobe Institute for Molecular Science La Trobe University, Australia
Harry Holthofer, University of Helsinki, Finland
Eva-Maria Krämer-Albers, Johannes Gutenberg University, Germany
Saara Laitinen, Finnish Red Cross Blood Service, Finland
Cecilia L ässer, University of Gothenburg, Sweden
Suresh Mathivanan, La Trobe University, Australia
Raymond Michel Schiffelers, University Medical Center Utrecht, Netherlands
Esther Nolte-'t Hoen, Utrecht University, Netherlands
Takahiro Ochiya, Nat Cancer Center Research Institute, Japan
Hector Peinado, Centro Nacional de Investigaciones Oncologicas, Spain
Kwang Pyo Kim, Kyung University, Seoul
Janusz Rak, McGill Cancer Research Centre, Canada
Neta Regev-Rudzki, Weizmann Institute of Science, Isreal
Marca Wauben, Utrecht University, Netherlands
Dr. Kenneth W Witwer, Johns Hopkins University School of Medicine, United States
|
